Lemelson Capital Management, LLC, a private investment management firm, today announced performance results for its flagship Amvona Fund, LP.
For 2016, The Amvona Fund returned 84.97 percent net of all fees and expenses, beating by 73 percent the benchmark S&P 500 Total Return Index, which returned 11.96 percent during the period. Since its September 2012 inception, The Amvona Fund, LP, has returned a compounded annualized rate or return of 23.81 percent net of all fees and expenses compared to 13.73 percent for the benchmark S&P 500 Total Return Index.
- Management increased its stake in Geospace Technologies, Inc. (NASDAQ: GEOS) from 5.55 percent of shares outstanding at year end 2015 to 9 percent at the close of 2016.
- Management substantially increased its short position in Domino’s Pizza, Inc. (NYSE: DPZ). As of year-end 2016, Domino’s is the largest short position in the fund.
- In December 2016, management issued a research report to the U.S. Senate Special Committee on Aging and the U.S. Food and Drug Administration (FDA) on abuse of federal regulations and statutes by Ligand Pharmaceuticals, Inc. (NASDAQ: LGND), a U.S.-based pharmaceutical company. In January 2016, the firm filed a whistleblower report with the U.S. Securities and Exchange Commission (SEC) on Ligand’s fraudulent accounting practices. Lemelson Capital’s letter to the U.S. Senate Special Committee on Aging can be read here
 The S&P 500 Total Return Index includes the reinvestment of dividends
Lemelson Capital Management, LLC, is a private investment management firm focused on deep value and special situation investments. Its flagship fund, The Amvona Fund, LP, has been named repeatedly among the world’s top performing hedge funds since its September 2012 inception.